Stock AIM AIM IMMUNOTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features AIM ImmunoTech Inc.

Equities

AIM

US00901B1052

Real-time Estimate Cboe BZX
Other stock markets
 02:40:26 2024-05-01 pm EDT 		5-day change 1st Jan Change
0.392 USD -4.04% Intraday chart for AIM ImmunoTech Inc. -9.30% -11.34%
Apr. 29 AIM ImmunoTech Says Safety Evaluation of First Dose Level of Pancreatic Cancer Study Completed MT
Apr. 10 AIM Immunotech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer CI

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AIM Stock
  4. News AIM ImmunoTech Inc.
  5. MarketScreener Editorial Features